World's Best Scientists 2026 revealed!
Joseph O. Moore

Joseph O. Moore

D-Index & Metrics

Medicine

D-Index
82
Citations
28210
World Ranking
15984
National Ranking
8044

Overview

Joseph O. Moore is affiliated with Duke University in the United States. Their research spans two main fields: Medicine and Engineering. Within these fields, they have contributed to subfields such as Hematology, Molecular Biology, Control and Systems Engineering, Ocean Engineering, and Mechanical Engineering.

The scientist's work addresses a range of topics including:

  • Hydraulic Fracturing and Reservoir Analysis
  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Drilling and Well Engineering
  • Histone Deacetylase Inhibitors Research
  • Robotic Path Planning Algorithms
  • Advanced Control Systems Optimization

Joseph O. Moore has published extensively, with notable recurring venues for publication including:

  • arXiv (Cornell University)
  • Blood
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
  • Journal of the National Comprehensive Cancer Network
  • Applied Thermal Engineering

The following recent papers highlight the scope and diversity of their research output:

  • "Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology" (2020), Journal of the National Comprehensive Cancer Network
  • "Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology" (2024), Journal of the National Comprehensive Cancer Network
  • "Utah FORGE: Well 16A(78)-32 Drilling Data" (2021), OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
  • "Overview and outlook of thermal processes in geothermal energy extraction" (2025), Applied Thermal Engineering
  • "Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell Lymphoma" (2021), Cancer Investigation

Collaboration plays an important part in Joseph O. Moore's research activities. Frequent co-authors include:

  • Marin Kobilarov
  • Deedra Nicolet
  • Krzysztof Mrózek
  • William Blum
  • Jonathan E. Kolitz

Best Publications

  • Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

    John C. Byrd;Krzysztof Mrózek;Richard K. Dodge;Andrew J. Carroll

  • Intensity of renal support in critically ill patients with acute kidney injury

    Paul M. Palevsky;Jane Hongyuan Zhang;Theresa Z. O'Connor;Glenn M. Chertow

  • Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

    Mayer Rj;Davis Rb;Schiffer Ca;Berg Dt

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

    Camille Abboud;Ellin Berman;Adam Cohen

  • Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia

    Richard M. Stone;Deborah T. Berg;Stephen L. George;Richard K. Dodge

  • Acute myeloid leukemia, version 3.2017: Clinical practice guidelines in oncology

    Margaret R. O'Donnell;Martin S. Tallman;Camille N. Abboud;Jessica K. Altman

  • High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.

    W. P. Peters;Elizabeth Shpall;Roy Jones;G. A. Olsen

  • Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia

    Krzysztof Mrózek;Guido Marcucci;Deedra Nicolet;Kati S. Maharry

  • Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study

    Guido Marcucci;Krzysztof Mrózek;Amy S. Ruppert;Kati Maharry

  • NCCN Clinical Practice Guidelines Acute myeloid leukemia.

    O'Donnell Mr;Abboud Cn;Altman J;Appelbaum Fr

  • TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.

    Klaus H. Metzeler;Kati Maharry;Michael D. Radmacher;Krzysztof Mrózek

  • Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered

    John C. Byrd;Richard K. Dodge;Andrew Carroll;Maria R. Baer

  • Randomized Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Sodium (Bcl-2 antisense) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

    Susan O'Brien;Joseph O. Moore;Thomas E. Boyd;Loree M. Larratt

  • A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy

    Isidore Tepler;Laurence Elias;John W. Smith;Mohamad Hussein

  • ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

    Klaus H. Metzeler;Heiko Becker;Kati Maharry;Kati Maharry;Michael D. Radmacher;Michael D. Radmacher

  • Age-Related Prognostic Impact of Different Types of DNMT3A Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia

    Guido Marcucci;Klaus H. Metzeler;Sebastian Schwind;Heiko Becker

  • Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia

    Eric J Feldman;Joseph Brandwein;Richard Stone;Matt Kalaycio

  • RUNX1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures

    Jason H. Mendler;Kati Maharry;Michael D. Radmacher;Krzysztof Mrózek

  • BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.

    Claudia D. Baldus;Stephan M. Tanner;Amy S. Ruppert;Susan P. Whitman

  • NCCN guidelines ® insights hodgkin lymphoma, version 1.2018 featured updates to the NCCN guidelines

    Richard T. Hoppe;Ranjana H. Advani;Weiyun Z. Ai;Richard F. Ambinder

Frequent Co-Authors

Clara D. Bloomfield
Clara D. Bloomfield The Ohio State University
Richard A. Larson
Richard A. Larson University of Chicago
Krzysztof Mrózek
Krzysztof Mrózek The Ohio State University
Bayard L. Powell
Bayard L. Powell Wake Forest University
J. Brice Weinberg
J. Brice Weinberg Duke University
Jonathan E. Kolitz
Jonathan E. Kolitz Hofstra University
Guido Marcucci
Guido Marcucci City Of Hope National Medical Center
Richard Stone
Richard Stone Harvard University
Susan P. Whitman
Susan P. Whitman The Ohio State University
Andrew J. Carroll
Andrew J. Carroll University of Alabama at Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering a career in Medicine or healthcare, several online degrees and certifications provide flexible and affordable ways to advance your education. Key pathways include nursing, pharmacy, health information management, and medical billing and coding.

Many current registered nurses look to msn to dnp programs online to achieve the Doctor of Nursing Practice degree, which opens doors to advanced leadership and clinical roles. Aspiring pharmacists are increasingly exploring online pharmacy school cost to find affordable and flexible PharmD programs.

For those interested in the data and administrative side of healthcare, completing rhia certification programs online can lead to specialized roles in health information management. Medical billing and coding is another in-demand field, and earning a medical coding certification online offers a quick entry into the healthcare workforce.

Each of these online pathways provides unique opportunities for professional growth in the healthcare sector, often with lower tuition and greater flexibility than traditional on-campus programs.

Best Scientists Citing Joseph O. Moore

Trending Scientists

Recently Published Articles